On August 20, 2025 Arcus Biosciences (NYSE:RCUS), a clinical-stage, global biopharmaceutical company focused on developing differentiated molecules and combination therapies for patients with cancer, reported that its management team will participate in the following upcoming investor conferences in September (Press release, Arcus Biosciences, AUG 20, 2025, View Source [SID1234655416]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Citi’s 2025 Biotech Back to School Conference
Date: Wednesday, September 3rd, 2025
Location: Boston, MA
Format: Fireside chat & 1×1 meetings
Time: 11:15 a.m. ET

H.C. Wainwright 27th Annual Global Investment Conference
Date: Tuesday, September 9th, 2025
Location: New York, NY
Format: Fireside chat & 1×1 meetings
Time: 8:00 a.m. ET

Morgan Stanley 23rd Annual Global Healthcare Conference
Date: Wednesday, September 10th, 2025
Location: New York, NY
Format: Fireside chat & 1×1 meetings
Time: 8:30 a.m. ET

Live webcasts of the fireside chats will be available by visiting the "Investors & Media" section of the Arcus Biosciences website at www.arcusbio.com. Replays will be available following the live event.